ZHU Guang-ying, YU Hui-ming, ZHENG Ming-ying. Intracranial Efficacy of Crizotinib Versus Chemotheropy in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(4): 218-221. DOI: 10.12019/j.issn.1671-5144.2016.04.009
|
Citation:
|
ZHU Guang-ying, YU Hui-ming, ZHENG Ming-ying. Intracranial Efficacy of Crizotinib Versus Chemotheropy in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(4): 218-221. DOI: 10.12019/j.issn.1671-5144.2016.04.009
|
ZHU Guang-ying, YU Hui-ming, ZHENG Ming-ying. Intracranial Efficacy of Crizotinib Versus Chemotheropy in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(4): 218-221. DOI: 10.12019/j.issn.1671-5144.2016.04.009
|
Citation:
|
ZHU Guang-ying, YU Hui-ming, ZHENG Ming-ying. Intracranial Efficacy of Crizotinib Versus Chemotheropy in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(4): 218-221. DOI: 10.12019/j.issn.1671-5144.2016.04.009
|
DownLoad: